EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study

Mohamed Samir iD, Abd Allah Abd Elaal, Khaled Abdel Sattar Gad, Mohamed Wagieh Basyony

International Journal of Urology · 2024

DOI: 10.1111/iju.15410 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Urology, 2024. Verfasst von Mohamed Samir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Transurethral Resection of Prostate, Quality of Life, Bacterial Toxins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Comparison of the efficacy and safety of Rezūm therapy and bipolar transurethral resection of prostate (B‐TURP) for the management of benign prostatic hyperplasia (BPH) of 50–120 g size.

Methods

One hundred patients with BPH who met the inclusion criteria were included and split into two equal groups to undergo Rezūm therapy or B‐TURP. The two groups were compared for efficacy using international prostate symptom score (IPSS), quality of life (QoL), maximum urinary flow rate (Q max ), operative time, catheter time, hospital stay, post‐void residual urine (PVR), prostate‐specific antigen (PSA), and residual prostate size and safety using the incidence of complications.

Results

Rezūm significantly ameliorated IPSS from the baseline score by 55.3%, QoL by 50%, Q max by 62.5%, International Index of Erectile Function (IIEF) by 7.1%, PVR by 50%, residual prostate size by 28.1% and PSA by 42% at 2 years. Meanwhile, the improvement in B‐TURP was significantly higher than Rezūm group, Rezūm therapy had a significantly shorter duration of operative time and hospital stay. Also, it had fewer complications in comparison with B‐TURP.

Conclusions

Rezūm is a minimally invasive procedure that provides significantly improved symptomatic relief of BPH and quality of life with preservation of erectile and ejaculatory functions. However, it is not as effective as B‐TURP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaTransurethral Resection of ProstateQuality of LifeBacterial ToxinsPore Forming Cytotoxic ProteinsHumansMaleAgedProspective StudiesFollow-Up StudiesMiddle AgedTreatment OutcomeProstatePostoperative ComplicationsProstate-Specific AntigenOperative TimeLength of Stay

Stichwörter der Autor:innen

BPHB‐TURPLUTSRezūmthermal therapy

Substanzen

Prostate-Specific AntigenPRX302Bacterial ToxinsPore Forming Cytotoxic Proteins

Autor:innen und Institutionen

  • Ain Shams University, Cairo, Egypt.
  • Military Medical Academy, Heliopolis, Egypt.

ORCID-Profile: Mohamed Samir

Zitieren

APA

Samir, M., Elaal, A. A. A., Gad, K. A. S., & Basyony, M. W. (2024). Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study. International Journal of Urology. https://doi.org/10.1111/iju.15410

Vancouver

Samir M, Elaal AAA, Gad KAS, Basyony MW. Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study. International Journal of Urology. 2024. doi:10.1111/iju.15410

BibTeX
@article{Samir2024,
  author = {Samir, Mohamed and Elaal, Abd Allah Abd and Gad, Khaled Abdel Sattar and Basyony, Mohamed Wagieh},
  title = {Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15410}
}
Kostenlos starten →